Education
About Us
Working with TipRanks
Follow Us
Becton, Dickinson and Co (BDX)
:BDX
Earnings Data
Report Date
Jan 29, 2026Before Open (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
2.81Last Year’s EPS
3.43Same Quarter Last Year
Moderate Buy
Based on 7 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
BD reported strong revenue and earnings growth, driven by high-performing segments like BD Interventional and Advanced Patient Monitoring. Operational efficiencies and strategic initiatives position BD for future growth. However, challenges such as declining vaccine demand, China market dynamics, and Alaris headwinds pose significant hurdles.Company Guidance
Record Revenue and EPS Growth
Q4 revenue reached $5.9 billion, an increase of 7%, with full-year revenue at a record $21.8 billion, up 7.7%. Adjusted diluted EPS for Q4 was $3.96 and $14.40 for the full year, representing 9.6% earnings growth.
Strong Growth in Key Segments
BD Interventional experienced high single-digit growth, driven by double-digit growth in PureWick and advanced tissue regeneration. Advanced Patient Monitoring grew double digits, performing well ahead of expectations.
Operational Efficiency and Margin Expansion
BD Excellence operating model drove strong P&L leverage, with adjusted gross margin up 140 basis points and adjusted operating margin expansion of 80 basis points. The company achieved a record 25% adjusted operating margin.
Strategic Initiatives to Drive Growth
BD announced initiatives including a $200 million cost-out program and expanded commercial focus with a newly appointed Chief Revenue Officer. Investments are being made in high-growth areas such as tissue regeneration and connected care.
Waters Transaction Progress
The combination of Biosciences and Diagnostic Systems with Waters is on track, with FTC clearance received and expected to close by the end of Q1 2026, unlocking significant shareholder value.
BDX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
BDX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 06, 2025 | $176.39 | $177.39 | +0.57% |
Aug 07, 2025 | $171.48 | $186.66 | +8.85% |
May 01, 2025 | $204.74 | $167.61 | -18.14% |
Feb 05, 2025 | $241.18 | $223.61 | -7.29% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Becton, Dickinson and Co (BDX) report earnings?
Becton, Dickinson and Co (BDX) is schdueled to report earning on Jan 29, 2026, Before Open (Confirmed).
What is Becton, Dickinson and Co (BDX) earnings time?
Becton, Dickinson and Co (BDX) earnings time is at Jan 29, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BDX EPS forecast?
BDX EPS forecast for the fiscal quarter 2026 (Q1) is 2.81.
